The Fra-2 transgenic strain develops lung fibrosis as well as abnormalities in other organs relevant to SSc.[11,12] Fibroblast directed activation of TGFbeta signalling confirms the importance of TGFbeta pathways in driving fibrosis. The gene discussed is TGFB1; the disease is pulmonary fibrosis.